![Shah Hussain](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Shah Hussain
Direktor/Vorstandsmitglied bei
MODERNA, INC.
Vermögen: 2 Mio $ am 31.08.2026
Profil
Shah Abbas Hussain bekleidet die Position eines Senior Partners bei Shanghai Kangshiqiao Business Consulting Co. Ltd. Er ist außerdem Mitglied des Verwaltungsrats von Teva Pharmaceutical Industries Ltd, Cochlear Ltd und TargTex SA sowie Präsident für aufstrebende Märkte im Asien-Pazifik-Raum bei GlaxoSmithKline South Africa (Pty) Ltd. Zuvor war er als Associate-Business Development bei Eli Lilly & Co. Präsident-Europageschäft bei Eli Lilly & Co. Ltd. General Manager der Lilly Deutschland GmbH, General Manager der Lilly Pharma Holding GmbH, Geschäftsführer der Lilly Ila Ticaret Ltd. Sti. Director-Sales & Marketing bei Eli Lilly Ranbaxy Ltd. und Manager-District Sales bei Eli Lilly Australia Pty Ltd. (alles Tochtergesellschaften von Eli Lilly & Co.) und Global President-Pharmaceuticals & Vaccines bei GlaxoSmithKline Plc und President-Emerging Markets & Asia Pacific bei Genelabs Technologies, Inc. (einer Tochtergesellschaft von GlaxoSmithKline Plc). Shah Abbas Hussain erwarb einen Bachelor-Abschluss an der Universität Loughborough.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 06.05.2026 | 12.066 ( 0 % ) | 2 Mio $ | 31.08.2026 |
Aktive Positionen von Shah Hussain
| Unternehmen | Position | Beginn |
|---|---|---|
| MODERNA, INC. | Direktor/Vorstandsmitglied | 02.10.2024 |
Alfasigma SpA
 Alfasigma SpA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for gastroenterology, immunology and vascular healthcare | Direktor/Vorstandsmitglied | - |
Asceneuron SA
 Asceneuron SA BiotechnologyHealth Technology Develops therapeutics for neurodegenerative disorders | Vorsitzender | - |
GlaxoSmithKline South Africa (Pty) Ltd.
 GlaxoSmithKline South Africa (Pty) Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline South Africa (Pty) Ltd. is a company based in Bryanston, South Africa. | Corporate Officer/Principal | 01.12.2009 |
Mallinckrodt Pharmaceuticals Ltd.
 Mallinckrodt Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Direktor/Vorstandsmitglied | 01.01.2024 |
Ehemalige bekannte Positionen von Shah Hussain
| Unternehmen | Position | Ende |
|---|---|---|
Vifor Pharma, Inc.
 Vifor Pharma, Inc. Medical/Nursing ServicesHealth Services Engages in iron deficiency, nephrology and cardio-renal therapies | Vorstandsvorsitzender | 01.01.2023 |
| COCHLEAR LIMITED | Direktor/Vorstandsmitglied | 20.07.2021 |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Direktor/Vorstandsmitglied | 06.07.2021 |
| CSL LIMITED | Direktor/Vorstandsmitglied | 25.06.2021 |
| ░░░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Shah Hussain
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
79
Beziehungen ersten Grades
25
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 25 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Teva Pharmaceutical Industries Ltd.
 Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
Genelabs Technologies, Inc.
 Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products and performs life science research and development | Health Technology |
CSL Ltd.
 CSL Ltd. BiotechnologyHealth Technology Develops and manufactures medicines that treat people with rare and serious diseases | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Cochlear Ltd.
 Cochlear Ltd. Medical SpecialtiesHealth Technology Develops, manufactures and markets implantable hearing solutions | Health Technology |
Aspen Pharmacare Holdings Ltd.
 Aspen Pharmacare Holdings Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals products | Health Technology |
Eli Lilly Ranbaxy Ltd.
 Eli Lilly Ranbaxy Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products | Health Technology |
Eli Lilly & Co. Ltd.
 Eli Lilly & Co. Ltd. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical health care solutions | Health Technology |
Loughborough University
 Loughborough University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lilly Deutschland GmbH
 Lilly Deutschland GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
GlaxoSmithKline South Africa (Pty) Ltd.
GlaxoSmithKline South Africa (Pty) Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline South Africa (Pty) Ltd. is a company based in Bryanston, South Africa. | Health Technology |
Eli Lilly Australia Pty Ltd.
 Eli Lilly Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | Health Technology |
Lilly Pharma Holding GmbH | |
ViiV Healthcare Ltd.
 ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Duke-NUS Graduate Medical School Singapore
 Duke-NUS Graduate Medical School Singapore Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Asceneuron SA
Asceneuron SA BiotechnologyHealth Technology Develops therapeutics for neurodegenerative disorders | Health Technology |
Lilly Ilaç Ticaret Ltd. Sti.
 Lilly Ilaç Ticaret Ltd. Sti. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
CBC Group (Singapore) Pte. Ltd.
 CBC Group (Singapore) Pte. Ltd. Investment ManagersFinance CBC Group invests in middle market companies located in China. The firm focuses on pharmaceutical, biotechnology, medical technology and healthcare service sectors. It provides financing in the form of equity, debt and non-dilutive financing for for buyout, growth, royalty acquisitions, structured transactions and hybrid financings. It acquires controlling stake in the company. | Finance |
Alfasigma SpA
Alfasigma SpA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for gastroenterology, immunology and vascular healthcare | Health Technology |
Mallinckrodt Pharmaceuticals Ltd.
Mallinckrodt Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Moderna, Inc.
 Moderna, Inc. BiotechnologyHealth Technology Researches, develops, manufactures and commercializes mRNA-based respiratory & other virus vaccines, oncology and rare disease therapeutics | Health Technology |
TargTex SA
 TargTex SA BiotechnologyHealth Technology Operates as a biotechnology company that develops therapies for oncology and cardiovascular diseases | Health Technology |
Immunocore Holdings Plc
 Immunocore Holdings Plc BiotechnologyHealth Technology Operates as a biotechnology company which develops immunotherapies | Health Technology |
Vifor Pharma, Inc.
Vifor Pharma, Inc. Medical/Nursing ServicesHealth Services Engages in iron deficiency, nephrology and cardio-renal therapies | Health Services |
